CN108018312A
|
|
A kind of CAR-T therapy vectors of T lymphocytic leukemias and its construction method and application
|
WO2018218875A1
|
|
Octs technology-based prostate cancer car-t therapeutic vector, construction method therefor, and use thereof
|
EP3505631A1
|
|
Human pd-1 knockdown sirna, recombinant expression car-t vector, preparation method thereof, and application of same
|
WO2018188331A1
|
|
Car-t cell with inhibited sterol o-acyltransferase 1 (soat1), preparation method therefor and application thereof
|
WO2018218878A1
|
|
Octs technology-based myeloid leukemia car-t therapeutic vector, construction method therefor and application thereof
|
CN107287207A
|
|
A kind of label and application for tracing in vivo and artificial removing CAR T cells
|
CN107325185A
|
|
The double targeting Chimeric antigen receptors of anti-PSCA and PDL1 based on OCTS CAR, encoding gene and expression vector
|
CN107337736A
|
|
The double targeting Chimeric antigen receptors of OCTS CAR, encoding gene, recombinant expression carrier and its structure and application
|
CN107267555A
|
|
A kind of glioblastoma CAR T therapy vectors and its construction method and application based on OCTS technologies
|
CN107299110A
|
|
A kind of cancer of pancreas based on OCTS technologies, malignant mesothelioma CAR T therapy vectors and its construction method and application
|
CN107245500A
|
|
A kind of pouring based on OCTS technologies is leukaemia CAR T therapy vectors and its construction method and application
|
CN108660111A
|
|
CAR-CIK transgenic cells and its preparation method and application
|
CN108148863A
|
|
A kind of CAR-T transgene carriers for being used to alleviate CRS for closing IL6R and its construction method and application
|
CN108148862A
|
|
It is a kind of close PDL1 for inhibiting the CAR-T transgene carriers of immune escape and its construction method and application
|
WO2018068354A1
|
|
Sirna of human interleukin 6, recombinant expression car-t vector, and construction method and use thereof
|